Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
(2025), in a retrospective cohort study published in the Journal of the American Academy of Dermatology, confirmed an increased incidence of alopecia in GLP-1 receptor agonist users
Polymorphism and ligand dependent changes in human glucagon-like peptide-1 receptor (GLP-1R) function: allosteric rescue of loss of function mutation
Are compounded tirzepatides as safe as brand-name versions
The Phase 2 trials showed participants losing an average of 24.2% of their body weight at the 12mg dose over 48 weeks
The STEP 5 trial demonstrated that mean weight loss of approximately 15% was maintained at week 104 with continued use of 2.4mg
US$ 23.48
US$ 26.08
US$ 24.94
US$ 28.59
US$ 23.77
US$ 23.24
US$ 24.99
